A two-step in vivo CRISPR screen unveils pervasive RNA binding protein dependencies for leukemic stem cells and identifies ELAVL1 as a therapeutic target

Supporters

Support the authors with ResearchCoin

Tip RSC

Preprint Server

Topics

Biology

Cancer Oncology

Genetics

Gene

Cell Biology

Show all topics

DOI

10.1101/2022.06.11.494613

License

CC-BY

Other Formats

PDF